Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

TEMPE, Ariz., May 13, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has authorized a new stock repurchase program. Under the program, Align may purchase up to $1.0 billion of its common stock over the next three years. This latest authorization follows a $600 million authorization announced on May 23, 2018 for which Align recently entered into a $100 million accelerated stock repurchase transaction on April 30, 2021 that is intended to complete that repurchase program.

Align Technology Announces a New $1 Billion Stock Repurchase Program

Updated GDC Policy Statement Affirms Requirement and Importance of a Physical Examination for Orthodontic Treatment and for Patients to Know the Full Name of the Dental Professional Responsible for their Orthodontic Treatment Updated GDC Policy Statement Affirms Requirement and Importance of a Physical Examination for Orthodontic Treatment and for Patients to Know the Full Name of the Dental Professional Responsible for their Orthodontic Treatment

Align Technology Supports the United Kingdom's General Dental Council (GDC) Statement on Direct-to-Consumer Orthodontics which Highlights Patient Safety Issues

Entegris

Trade Desk

The tailwinds are picking up for these companies.

3 Top Growth Stocks to Buy in May

ABIOMED

People will be getting back to their regular routines when it comes to medical and dental care.

The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts

SAN FRANCISCO--(BUSINESS WIRE)---- $ALGN #ALGN--Invisalign purchasers filed a class-action lawsuit against maker of Invisalign, Align Technology, for an alleged monopoly, according to Hagens Berman.

Hagens Berman: Invisalign Lawsuit Says Consumers Overpaid for Dental Aligners Due to Scheme by Align

DENTSPLY SIRONA

XRAY vs. ALGN: Which Stock Is the Better Value Option?

XRAY vs. ALGN: Which Stock Should Value Investors Buy Now?

Align Technology's (ALGN) segments report solid Q1 sales across geographies despite the pandemic-led business challenges.

Align Technology (ALGN) Q1 Earnings Beat Estimates, Margins Up

There was a lot to like with the orthodontic device maker's latest quarterly performance.

Align Technology Gives Investors Something to Smile About With Its Record Q1 Results

Align Technology, Inc. (ALGN) CEO Joseph Hogan on Q1 2021 Results - Earnings Call Transcript

Align Technology (ALGN) delivered earnings and revenue surprises of 25.13% and 8.54%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Align Technology (ALGN) Beats Q1 Earnings and Revenue Estimates

Shares of Align Tech (NASDAQ:ALGN) rose after the company reported Q1 results. Quarterly Results Earnings per share increased 241.10% year over year to $2.49, which beat the estimate of $2.02.

Recap: Align Tech Q1 Earnings

TEMPE, Ariz., April 28, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today reported financial results for the first quarter of fiscal 2021 ("Q1'21"). Q1'21 total revenues were $894.8 million, up 62.4% year-over-year. Q1'21 Clear Aligner revenues were $753.3 million, up 56.4% year-over-year and Q1'21 Imaging Systems and CAD/CAM Services revenues were $141.5 million, up 104.0% year-over-year. Q1'21 Clear Aligner volume was 595.8 thousand cases, up 65.8% year-over-year. For the Americas and International regions, Q1'21 Clear Aligner volume was up 53.8% and up 83.2% year-over-year, respectively. Q1'21 Clear Aligner volume for teenage patients was 165.3 thousand cases, up 58.9% year-over-year. Q1'21 operating income of $225.4 million was up 222.4% year-over-year, resulting in an operating margin of 25.2%. Q1'21 GAAP net income was $200.4 million, or $2.51 per diluted share. On a non-GAAP basis, Q1'21 net income was $198.4 million, or $2.49 per diluted share.

Align Technology Announces Record First Quarter 2021 Financial Results

Seperately DECA is equipping DECA-affiliated practices in the US with iTero Element 5D imaging systems to aid diagnostics, patient engagement and digital workflows Seperately DECA is equipping DECA-affiliated practices in the US with iTero Element 5D imaging systems to aid diagnostics, patient engagement and digital workflows

Align Technology and DECA Dental Group Extend Multi-Year Agreement For Invisalign Clear Aligners in the US

Company hopes to inspire others to share their smiles using #10MInvisalignSmiles

Align Celebrates 10 Million Invisalign Smiles With 10 Million Thanks – Donates $10 Million to the Align Foundation to Fund Organizations That Transform Smiles, and Support and Educate Teens

Abbott Labs

Boston Scientific

Quest Diagnostics

Hologic

Integra LifeSciences Holdings

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Medical Product Stocks' Earnings on Apr 28: BSX, ALGN & More

Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Earnings Surprise Streak Could Continue for Align Technology (ALGN)

Charles River Laboratories

Medpace Holdings

Medical stocks Medpace Holdings and Charles River Laboratories were making inroads toward profit-taking zones on Friday as Align Technology flirted with a breakout out of a cup base. The post Three Scorching Medical Stocks To Watch, Including One Near A Buy Point appeared first on Investor's Business Daily.

Three Scorching Medical Stocks To Watch, Including One Near A Buy Point

With Q1 earnings due, ALGN stock is lining up a breakout as the 3D printing leader and maker of Invisalign clear braces expands globally. The post Breakout Watch: World's Largest 3D Printer Smiling Ahead Of Earnings appeared first on Investor's Business Daily.

Breakout Watch: World's Largest 3D Printer Smiling Ahead Of Earnings

WROCLAW, Poland and TEMPE, Ariz. and ROTKREUZ, Switzerland, April 22, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company engaged in the design and manufacture of the Invisalign system, iTero intraoral scanners, and exocad CAD/CAM services for orthodontic and restorative dentistry, today announced plans to open a new manufacturing facility in Poland to address the large and underpenetrated market opportunity in the Europe, Middle East and Africa (EMEA) region, which represents over 5 million annual orthodontic case starts and more than 150 million EMEA consumers who can potentially benefit from a healthier, beautiful smile. The new Wroclaw plant will be Align's first in the EMEA region and its third plant worldwide, joining Juarez, Mexico and Ziyang, China.

Align Technology Expands Global Operations to Support Growth and Adoption of the Invisalign System in EMEA With Plans for Multi-Million Dollar Manufacturing Facility in Wroclaw, Poland

ResMed

Vertex Pharmaceuticals

Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market.

3 Top Value Stocks in Healthcare to Buy Right Now

Align Technology is near a possible buy zone ahead of its next quarterly earnings report, expected on or around Apr. 28. The post Stocks To Watch Ahead Of Earnings: Align Technology appeared first on Investor's Business Daily.

Stocks To Watch Ahead Of Earnings: Align Technology

Align Technology (ALGN) closed at $603.72 in the latest trading session, marking a -0.43% move from the prior day.

Align Technology (ALGN) Stock Moves -0.43%: What You Should Know

Does Align Technology (ALGN) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes Align Technology (ALGN) a Strong Momentum Stock: Buy Now?

As of late, it has definitely been a great time to be an investor in Align Technology (ALGN).

Align Technology's (ALGN) Shares March Higher, Can It Continue?

ICON

PRA Health Sciences

STERIS

Teladoc

Thermo Fisher Scientific

While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.

News for Align Technology Stock (ALGN)